Cancer-Causing Proteins Camp Lejeune NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Laura M Decastro, MD
(919) 684-6464
Erwin Road,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Auto De Santo Domingo (Uasd), Fac De Cien Med, Santo Domingo
Graduation Year: 1986

Data Provided by:
John Cho, MD
(252) 636-5135
1915 Trent Blvd
New Bern, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Languages
Spanish
Education
Medical School: Univ Of Pittsburgh Sch Of Med, Pittsburgh Pa 15261
Graduation Year: 1987
Hospital
Hospital: Craven Reg Med Authority, New Bern, Nc
Group Practice: Coastal Oncology & Hematology

Data Provided by:
Mark T Wimmer
(704) 636-5542
825 W Henderson St
Salisbury, NC
Specialty
Medical Oncology

Data Provided by:
Nancy Rebecca Haley, MD
(703) 319-9377
3720 Saint Marks Rd
Durham, NC
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Eastern Va Med Sch Of The Med Coll Of Ha
Graduation Year: 1984

Data Provided by:
Robert L Cirillo Jr, MD
(919) 309-6300
4323 Ben Franklin Blvd Ste 500
Durham, NC
Specialties
Radiology, Hematology-Oncology
Gender
Male
Education
Medical School: Georgetown Univ Sch Of Med, Washington Dc 20007
Graduation Year: 1994

Data Provided by:
Paul Edward Monahan II, MD
101 Manning Dr
Chapel Hill, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Va Sch Of Med, Charlottesville Va 22908
Graduation Year: 1990

Data Provided by:
John Burnett Holt
(704) 384-4814
200 Hawthorne Lane
Charlotte, NC
Specialty
Hematology

Data Provided by:
Heather Stuart Shaw, MD
(919) 668-0718
DUMC Box 3381,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1993

Data Provided by:
Arthur W Blackstock Jr, MD
(336) 716-9212
Medical Center Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: East Carolina Univ Sch Of Med, Greenville Nc 27858
Graduation Year: 1989

Data Provided by:
Keith Michael Sullivan, MD
(919) 668-1011
Dumc Box 3961,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: In Univ Sch Of Med, Indianapolis In 46202
Graduation Year: 1971

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com